Phillips Medisize will be exhibiting at the Respiratory Drug Delivery Conference (RDD), taking place May 10–14, 2026, at the Westin Kierland in Phoenix, Arizona.
During the conference, our team will contribute to the program across multiple formats, highlighting innovation in inhaled drug delivery:
- Podium Presentation:
Routes to Technologically Advanced Inhaled Delivery Devices, and Potential Strategies to Increase the Likelihood of Success
Speaker: Andreas Meliniotis, Vice President of Device Development
- Workshop
Patient-Centric Product Development: Maximizing the Chances of Success in the Clinic and Beyond
Facilitators: Daniel Lock, Senior Manager and Nicola Wilkie, Team Leader
- Poster Presentation:
Development of the Open-Inhale-Close (OIC) Device with Connectivity for Patient-Centric and Nonintrusive Dry Powder Delivery
Authors: Murat Ali, Associate Director of Device Development; Philip Smith, Principal Engineer of Device Development; Phil Swanbury, Director of Device Development; Mourad Jelili, Senior Engineer Electronic Engineering; John Deamer, Senior Design Engineer; Amy Naylor, Placement Student Engineering; and Andreas Meliniotis, Vice President of Device Development
We invite you to visit us at our table to learn more about our inhalation drug delivery device innovations and our regional manufacturing capabilities.
If you’d like to schedule a meeting with our team during the conference, please fill out our Contact Us form and we will follow up with you.
Our Inhalation CDMO Capabilities
The 2025 Vectura acquisition expanded our capabilities. Today, Phillips Medisize specializes in innovative inhaled drug development, leveraging more than 25 years of experience to help bring your medicines to market. Our combination of formulation science, device technology and inhaled development expertise has contributed to the success of 13 inhaled medicines launched by our partners and licensees.
Want to Meet Now?
To schedule a meeting with one of our subject-matter experts, please fill out the Contact Us form and we will follow up with you.